{"nct_id":"NCT02606136","title":"Trial of Pamrevlumab (FG-3019), in Non-Ambulatory Participants With Duchenne Muscular Dystrophy (DMD)","status":"TERMINATED","status_verified_date":"2024-07","start_date":"2016-01-04","start_date_type":"ACTUAL","primary_completion_date":"2020-05-07","primary_completion_date_type":"ACTUAL","completion_date":"2023-08-09","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["FGEN"]}